Clinical trial
Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With…
NCT00143377 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00143377 |
|---|---|
| Title | Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB |
| Official title | A Global Phase IV, Double-Blind, Placebo-Controlled, Randomized Trial To Evaluate The Effectiveness Of Detrusitol Sr 4mg On Patient's Perception Of Bladder Condition (PPBC). |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Urinary Incontinence |
| Intervention type | Drug |
| Interventions | tolterodine SR, overactive bladder |
| Enrollment | 600 |
| Start date | Sep 1, 2004 |
| Completion | Oct 1, 2005 |
| First posted | Sep 2, 2005 |
| Last update posted | Jan 27, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: